Live
ePaper
Search
Home > India > BRIEF-Knight Therapeutics – Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia

BRIEF-Knight Therapeutics – Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia

Written By:
Last Updated: October 6, 2026 17:19:24 IST

Oct 6 (Reuters) – Knight Therapeutics Inc: * KNIGHT THERAPEUTICS – LAUNCHES TAVALISSE IN BRAZIL FOR CHRONIC IMMUNE THROMBOCYTOPENIA Source text: Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?